Aqr Capital Management LLC Meridian Bioscience Inc Transaction History

Aqr Capital Management LLC

$71.5 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$23.75 - $31.69 $97,375 - $129,929	4,100 Added 35.28%	15,722 $478,000
Q1 2022 May 16, 2022	SELL	$19.97 - $26.94 $90,024 - $121,445	-4,508 Reduced 27.95%	11,622 $302,000
Q4 2021 Feb 14, 2022	SELL	$17.46 - $21.61 $376,018 - $465,392	-21,536 Reduced 57.18%	16,130 $329,000
Q3 2021 Nov 15, 2021	SELL	$17.35 - $22.5 $306,938 - $398,047	-17,691 Reduced 31.96%	37,666 $725,000
Q2 2021 Aug 16, 2021	SELL	$18.01 - $28.32 $532,537 - $837,394	-29,569 Reduced 34.82%	55,357 $1.23 Million
Q1 2021 May 17, 2021	SELL	$19.76 - $29.89 $789,194 - $1.19 Million	-39,939 Reduced 31.99%	84,926 $2.23 Million
Q4 2020 Feb 16, 2021	SELL	$15.73 - $21.66 $628,067 - $864,840	-39,928 Reduced 24.23%	124,865 $2.33 Million
Q3 2020 Nov 16, 2020	BUY	$13.54 - $26.41 $470,853 - $918,407	34,775 Added 26.75%	164,793 $2.8 Million
Q2 2020 Aug 17, 2020	SELL	$7.84 - $23.29 $1.2 Million - $3.57 Million	-153,309 Reduced 54.11%	130,018 $3.03 Million
Q1 2020 May 15, 2020	BUY	$5.57 - $11.5 $29,470 - $60,846	5,291 Added 1.9%	283,327 $2.38 Million
Q4 2019 Feb 14, 2020	BUY	$7.9 - $10.14 $1.1 Million - $1.41 Million	139,496 Added 100.69%	278,036 $2.72 Million
Q3 2019 Nov 14, 2019	BUY	$9.17 - $12.01 $344,370 - $451,023	37,554 Added 37.19%	138,540 $1.32 Million
Q2 2019 Aug 14, 2019	BUY	$10.88 - $17.6 $414,092 - $669,856	38,060 Added 60.48%	100,986 $1.2 Million
Q1 2019 May 14, 2019	BUY	$15.51 - $17.61 $212,331 - $241,080	13,690 Added 27.8%	62,926 $1.11 Million
Q4 2018 Feb 14, 2019	SELL	$14.52 - $19.72 $721,556 - $979,965	-49,694 Reduced 50.23%	49,236 $855,000
Q3 2018 Nov 15, 2018	BUY	$14.85 - $16.35 $492,856 - $542,640	33,189 Added 50.48%	98,930 $1.47 Million
Q2 2018 Aug 14, 2018	BUY	$13.8 - $16.8 $5,906 - $7,190	428 Added 0.66%	65,741 $1.05 Million
Q1 2018 May 15, 2018	BUY	$13.8 - $16.2 $245,433 - $288,117	17,785 Added 37.42%	65,313 $928,000
Q4 2017 Feb 14, 2018	BUY	$13.55 - $15.8 $164,713 - $192,064	12,156 Added 34.37%	47,528 $666,000
Q3 2017 Nov 14, 2017	BUY	$13.45 - $14.35 $475,753 - $507,588	35,372	35,372 $506,000

Others Institutions Holding VIVO

# of Institutions

Shares Held

113K

Call Options Held

Put Options Held

View Full List

About MERIDIAN BIOSCIENCE INC

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

More about VIVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account